Upgrade

Pediatrix Medical Group, Inc.

MD

Last
$26.64
Day
+1.5%
1y
+61.8%
5y
-7.5%
52w
-6.1%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0223d
EMA 21
26.12
EMA 50
26.05
EMA 200
23.56
20d high
-4.0%
5y high
-9.7%
5y range
87th
Website · 4,280 employees · United States

Positions held

Your positions

MD isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
23
Hold
swing
Signal
Buy
Target
$28.52
Stop
$25.10
Stop distance
5.8%
Target vs last
+7.1%

Bull / bear case

Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.

Bull case
  • Pediatrix Medical Group operates in a growing healthcare sector, focusing on specialized medical care facilities which are increasingly in demand as the population ages.
  • In the latest quarter, revenue increased by 2% compared to the prior quarter, reaching $488 million.
  • The operating margin expanded to 13.4%, reflecting improved operational efficiency.
Bear case
  • The company has a high debt-to-equity ratio of 70.371, which may pose risks in a rising interest rate environment.
  • In 2024, Pediatrix reported a net income loss of $99.069 million, indicating financial instability.
  • The trailing P/E ratio is 12.5, which may suggest the stock is undervalued, but could also reflect market skepticism about future growth.

Fundamentals

Market cap$2.13BEnterprise value$2.30BTrailing P/E12.56Forward P/E10.75
PEG0.24Price / book2.36Beta0.61Dividend yield0.00%
Revenue growth4.0%Earnings growth6.5%Gross margin26.2%Operating margin13.4%
Profit margin9.0%ROE20.4%ROA7.1%Debt / equity0.70
Current ratio1.32Free cash flow$160.78MAnalyst recommendationholdMean target$26.33
52w high$27.9452w low$15.70

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q2
Revenue$488M$476M$494M$493M$469M
Op margin13.4%9.8%11.1%15.0%13.6%
Net income$39.8M$29.6M$33.7M$71.7M$39.3M
Gross margin27.2%23.7%25.5%28.5%26.6%
Gross profit$132M$113M$126M$140M$125M
Operating income$65.4M$46.6M$54.7M$74.0M$63.7M
  • Revenue +2% vs prior quarter ($488M vs $476M).
  • Gross margin 27.2% (was 23.7% prior quarter).
  • Operating margin expanded to 13.4%.

Yearly (6y)

20252024202320222021
Revenue$1.9B$2.0B$2.0B$2.0B—
Op margin12.1%9.1%7.9%10.1%—
Net income$165M-$99.1M-$60.4M$66.3M—
Gross margin25.8%22.6%21.1%23.7%—
Gross profit$494M$454M$422M$467M—
Operating income$231M$184M$158M$200M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

MD · daily-0.4% over 13 sessions
Close EMA21 EMA50 EMA200
25.3325.7226.1126.5026.892026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
$0M$123M$247M$370M$494M0%14%28%2025-Q22025-Q32025-Q42026-Q12026-Q2